Screener
Cytokinetics CYTK Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: Cytokinetics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:30 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338217
FAQ
- What is Cytokinetics's accounts payable?
- Cytokinetics (CYTK) reported accounts payable of $20.51M in Q2 2026.
- How has Cytokinetics's accounts payable changed year-over-year?
- Cytokinetics's accounts payable increased by 26.4% year-over-year, from $16.23M to $20.51M.
- What is the long-term trend for Cytokinetics's accounts payable?
- Over 5 years (2020 to 2025), Cytokinetics's accounts payable has grown at a 22.6% compound annual growth rate (CAGR), from $8.05M to $22.34M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about Cytokinetics's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude